PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...

Read more →

PHARMAC knew of epilepsy drug change risks - inquest

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...

Read more →

PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines.  ...

Read more →

Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands

23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...

Read more →

Maker of epilepsy drug warned over quality control

23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...

Read more →

Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes

22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...

Read more →

Does NICE influence the adoption and uptake of generics in the UK?

14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...

Read more →

FDA’s generic drug program in 2020 helped ensure availability of high quality, affordable drugs amid COVID-19

11 February 2021 - Generic drugs play a vital role in facilitating access to lifesaving medicines for Americans and remain a ...

Read more →

Billionaire Mark Cuban wants to lower drug prices with generics startup

15 January 2021 - Billionaire Mark Cuban is mad about the high cost of prescription drugs in the United States, ...

Read more →

Amneal launches generic abiraterone acetate 500 mg tablets following ANDA approval by FDA

8 January 2021 - Amneal Pharmaceuticals announced that it has received approval of an additional strength of 500 mg to its ...

Read more →

FDA approves first generic of drug used to treat severe hypoglycaemia

28 December 2020 - Today, the U.S. FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in ...

Read more →

Hikma launches generic Advair Diskus following FDA approval

17 December 2020 - Hikma Pharmaceuticals announces it has received FDA approval for and launched its generic version of GlaxoSmithKline’s ...

Read more →

FDA updates list of off-patent, off-exclusivity drugs without an approved generic

17 December 2020 - Today, the U.S. FDA published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved ...

Read more →

GPs tell inquest they were unaware PHARMAC changed their patients' epilepsy drugs

30 November 2020 - Two GPs caring for patients who died after switching brands of an epilepsy drug say they were ...

Read more →

Sudden epilepsy deaths: grieving mum speaks out ahead of coronial inquest

28 November 2020 - Michelle Townes believes her 31-year-old son died because the brand of his Government funded drug was switched.  ...

Read more →